Royal Bank Of Canada Novo Cure LTD Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Novo Cure LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 8,230 shares of NVCR stock, worth $160,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,230
Previous 22,312
63.11%
Holding current value
$160,402
Previous $348,000
29.6%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$236 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$230 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$173 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$93.9 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$53.4 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.05B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...